Eltoptazine may be the sleeper that is going to light the fire for AMBS. The initiation of the Phase 2b trial is due to be announced any day, and mkt reaction could be very positive. JP shared this link on the other board, a very intriguing read, extremely positive for Eltoprazine!
http://www.businesswire.com/news/home/2012061...NTJho10zIV